Skip to main content

Table 3 Depression scores (PHQ-9) and anti-depressant use by wave and treatment arm

From: Collaborative care compared to enhanced standard treatment of depression with co-morbid medical conditions among patients from rural South India: a cluster randomized controlled trial (HOPE Study)

 

Treatment arm

Difference in change from BL between arms

 

Wave

Variable

Collaborative care

(24 PHCs)

Enhanced standard care (25 PHCs)

p-value

Baseline

On antidepressants: n (%)

1

(0.1%)

0

(0%)

  
 

PHQ-9 score: observed mean (SD)

8.47

(3.95)

8.58

(4.29)

3 months

On antidepressants: n (%)

233

(25.9%)

8

(0.9%)

 

PHQ-9 score: observed mean (SD)

5.24

(3.21)

6.69

(3.73)

0.002a

Predicted change in PHQ-9 from BLb

−3.11

 

−1.83

 

−1.28

< 0.001

6 months

On antidepressants: n (%)

223

(26.0%)

10

(1.3%)

  
 

PHQ-9 score: observed mean (SD)

4.81

(2.98)

6.13

(3.42)

< 0.001a

Predicted change in PHQ-9 from BLb

−3.52

 

−2.22

 

−1.31

< 0.001

12 months

On antidepressants: n (%)

252

(27.5%)

10

(1.2%)

  
 

PHQ-9 score: observed mean (SD)

4.22

(2.65)

5.23

(2.71)

< 0.001a

Predicted change in PHQ-9 from BLb

−4.06

 

−3.00

 

−1.06

< 0.001

  1. a Based on univariable regression of PHQ-9 score on treatment arm per wave, using cluster (PHC) robust standard errors
  2. b Based on multi-level linear regression of the repeated measurements of PHQ-9 on wave, treatment arm and wave*treatment arm, with random intercepts for participant and PHC (ICCPHC = 0.13, ICCPartic.|PHC = 0.31)